Gradient Investments’s Imunon IMNN Stock Holding History

Gradient Investments’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1	Closed	–	–	1429
2022 Q2	$0	Hold	1	–	–	﹤0.01%	1290
2022 Q1	$0	Sell	1 -4	-80%	-$314	﹤0.01%	1253
2021 Q4	$1K	Hold	5	–	–	﹤0.01%	1153
2021 Q3	$1K	Hold	5	–	–	﹤0.01%	1080
2021 Q2	$1K	Hold	5	–	–	﹤0.01%	1078
2021 Q1	$1K	Hold	5	–	–	﹤0.01%	1087
2020 Q4	$1K	Hold	5	–	–	﹤0.01%	1051
2020 Q3	$1K	Hold	5	–	–	﹤0.01%	1056
2020 Q2	$4K	Hold	5	–	–	﹤0.01%	779
2020 Q1	$1K	Hold	5	–	–	﹤0.01%	1004
2019 Q4	$2K	Hold	5	–	–	﹤0.01%	942
2019 Q3	$2K	Hold	5	–	–	﹤0.01%	929
2019 Q2	$2K	Hold	5	–	–	﹤0.01%	878
2019 Q1	$2K	Hold	5	–	–	﹤0.01%	748
2018 Q4	$1K	Hold	5	–	–	﹤0.01%	872
2018 Q3	$3K	Hold	5	–	–	﹤0.01%	806
2018 Q2	$3K	Hold	5	–	–	﹤0.01%	774
2018 Q1	$2K	Hold	5	–	–	﹤0.01%	825
2017 Q4	$3K	Buy	+5	New	+$2.84K	﹤0.01%	759

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

IAMOG

Investors Asset Management of Georgia Atlanta, Georgia $244M AUM 26.8% 1-Year Est. Return

Gradient Investments's IMNN Position: Q3 2022 in Review

Gradient Investments sold out of Imunon (IMNN) in Q3 2022, closing a stake of 1 share.

Gradient Investments first reported a position in IMNN in Q4 2017 and held it in 19 quarters. The position peaked at $4K in Q2 2020. 21 funds tracked by Wall St. Rank hold IMNN as of Q3 2022.

Gradient Investments reported no remaining Imunon position as of Q3 2022 after selling out during the quarter.
Gradient Investments sold 1 Imunon share in Q3 2022.
Gradient Investments first reported a position in Imunon in Q4 2017 and held it in 19 quarters.
Gradient Investments's Imunon position peaked at $4K in Q2 2020.
21 funds tracked by Wall St. Rank held Imunon as of Q3 2022.

Based on Gradient Investments's 13F filing for Q3 2022, filed 14 Oct 2022.